The 11 linked references in paper Zh. Mironova A., E. Vsevolodskaya I., V. Trofimov I., A. Ulitina S., S. Pchelina N., M. Dubina V., S. Gorbunkov D., A. Akopov L., Ж. Миронова А., Е. Всеволодская И., В. Трофимов И., А. Улитина С., С. Пчелина Ф., М. Дубина В., С. Горбунков Д., А. Акопов Л. (2017) “Фармакогенетические и эпигенетические особенности синдрома перекреста бронхиальной астмы и хронической обструктивной болезни легких // Pharmacogenetic and epigenetic features of asthma-COPD overlap syndrome” / spz:neicon:pulmonology:y:2017:i:1:p:7-11

  1. Pleasants R.A., Ohar J.A., Croft J.B. et al. Chronic obstructive pulmonary disease and asthma: patient characteristics and health impairment. COPD. 2014; 11 (3): 256–266. DOI: 10.3109/15412555.2013.840571. 11
  2. Xu Q., Leung D.Y., Kisich K.O. Serine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor beta in neutrophils.J. Biol. Chem.2003; 278 (29): 27112–27118. DOI: 10.1074/jbc.M300824200.
  3. Li L.B., Leung D.Y., Hall C.F., Goleva E. Divergent expression and function of glucocorticoid receptor βin human monocytes and T-cells. J. Leukoc. Biol.2006; 79 (4): 818–827. DOI: 10.1189/jlb.0805466.
  4. Kelly A., Bowen H., Jee Y.K. et al. The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases. J. Allergy Clin. Immunol. 2008; 121 (1): 203–208. DOI: 10.1016/j.jaci.2007.09.010.
  5. Barnes P.J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol.2013; 131 (3): 636–645. DOI: 10.1016/j.jaci. 2012.12.1564.
  6. Ito K., Caramori G., Adcock I.M. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.J. Pharmacol. Exp. Ther. 2007; 321 (1): 1–8. DOI: 10.1124/jpet.106.111674.
  7. Mercado N., To Y., Ito K., Barnes P.J. Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase δ. J. Pharmacol. Exp. Ther.2011; 337 (2): 465–470. DOI: 10.1124/jpet.110.175950.
  8. Butler C.A., McQuaid S., Taggart C.C. et al. Glucocorticoid receptor b and histone deacetylase 1 and 2 expression in the airways of severe asthma. Thorax. 2012; 67 (5): 392–398. DOI: 10.1136/thoraxjnl-2011-200760.
  9. Welte T., Miravitlles M., Hernandez P. et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.2009; 180 (8): 741–750. DOI: 10.1164/rccm.200904-0492OC.
  10. Magnussen H., Bugnas B., van Noord J. et al. Improvements with tiotropium in COPD patients with concomitant asthma.Respir. Med.2008; 102 (1): 50–56. DOI: 10.1016/ j.rmed.2007.08.003.
  11. To Y., Ito K., Kizawa Y. et al. Targeting phosphoinositide-3kinase-δwith theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.2010; 182 (7): 897–904. DOI: 10.1164/rccm.200906-0937OC.